Replimune Group, Inc. (REPL)
13.11
+0.24
(+1.86%)
USD |
NASDAQ |
Sep 18, 14:01
Replimune Group 30-Day Average Daily Volume : 3.257M for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 3.257M |
| September 16, 2026 | 3.309M |
| September 15, 2026 | 3.451M |
| September 14, 2026 | 3.772M |
| September 11, 2026 | 4.815M |
| September 10, 2026 | 4.721M |
| September 09, 2026 | 5.076M |
| September 08, 2026 | 5.840M |
| September 04, 2026 | 6.073M |
| September 03, 2026 | 6.151M |
| September 02, 2026 | 6.232M |
| September 01, 2026 | 6.220M |
| August 31, 2026 | 6.297M |
| August 28, 2026 | 6.383M |
| August 27, 2026 | 6.427M |
| August 26, 2026 | 6.490M |
| August 25, 2026 | 6.464M |
| August 24, 2026 | 6.469M |
| August 21, 2026 | 6.494M |
| August 20, 2026 | 6.472M |
| August 19, 2026 | 6.420M |
| August 18, 2026 | 6.414M |
| August 17, 2026 | 6.410M |
| August 14, 2026 | 6.340M |
| August 13, 2026 | 6.354M |
| Date | Value |
|---|---|
| August 12, 2026 | 6.346M |
| August 11, 2026 | 6.215M |
| August 10, 2026 | 6.180M |
| August 07, 2026 | 6.218M |
| August 06, 2026 | 5.995M |
| August 05, 2026 | 5.848M |
| August 04, 2026 | 5.851M |
| August 03, 2026 | 5.752M |
| July 31, 2026 | 5.445M |
| July 30, 2026 | 4.468M |
| July 29, 2026 | 4.478M |
| July 28, 2026 | 4.067M |
| July 27, 2026 | 3.332M |
| July 24, 2026 | 3.119M |
| July 23, 2026 | 3.122M |
| July 22, 2026 | 3.083M |
| July 21, 2026 | 3.134M |
| July 20, 2026 | 3.152M |
| July 17, 2026 | 3.245M |
| July 16, 2026 | 3.422M |
| July 15, 2026 | 3.510M |
| July 14, 2026 | 3.823M |
| July 13, 2026 | 5.425M |
| July 10, 2026 | 5.394M |
| July 09, 2026 | 5.391M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Moderna, Inc. | 25.72M |
| Kalaris Therapeutics, Inc. | 54592.67 |
| Arrowhead Pharmaceuticals, Inc. | 1.516M |
| Oncolytics Biotech, Inc. | 845959.6 |
| Sangamo Therapeutics, Inc. | 3.233M |